Back to Results
First PageMeta Content
Microbiology / Bacterial diseases / Proteobacteria / Meningococcal disease / Meningococcal vaccine / NmVac4-A/C/Y/W-135 / Neisseria meningitidis / Asplenia / Meningitis / Bacteria / Medicine / Vaccines


Chapter 13 Meningococcal Infection Meningococcal Infection Group C vaccine introduced 2000 NOTIFIABLE
Add to Reading List

Open Document

File Size: 206,17 KB

Share Result on Facebook

City

Mecca / /

Company

Serogroup / Meningococcal Infection Year Total Serogroup B Serogroup / Chapter 13 Meningococcal Infection Year Total Serogroup / Year Other Serogroup C Serogroup / /

Country

Norway / New Zealand / Ireland / /

MedicalCondition

severe respiratory tract infection / invasive infection / disease / seizures / meningism / strain / shock / meningococcal meningitis / chronic renal failure / endophthalmitis / Introduction Meningococcal infections / influenza A / tetanus / recurrent meningococcal disease / properdin deficiency / infectious / fever / bacterial meningitis / recurrent meningococcal infections / severe infection / meningococcal disease / septicaemia / septic arthritis / meningococcal infection / sporadic infection / diseases / hyperendemic disease / epidemics / invasive infections / infection / illness / hearing loss / infections / meningitis / rash / Epidemic disease / sepsis / /

MedicalTreatment

antibiotics / amputation / vaccination / Chemoprophylaxis / /

Organization

IMD / /

Product

penicillin / ciprofloxacin / ceftriaxone / /

Region

sub-Saharan Africa / Northern Europe / /

Technology

CRM / antibodies / pdf / /

URL

www.imb.ie / http /

SocialTag